Cargando…
Accumulation of Arsenic Speciation and In Vivo Toxicity Following Oral Administration of a Chinese Patent Medicine Xiao-Er-Zhi-Bao-Wan in Rats
Realgar-containing traditional Chinese medicines such as Xiao-Er-Zhi-Bao-Wan (XEZBW), have been widely used for thousands of years. However, events associated with arsenic-induced ailments have increasingly become a public concern. To address the toxicity of XEZBW, we studied the histopathology and...
Autores principales: | Luo, Jiaoyang, Han, Xu, Dou, Xiaowen, Zhang, Lei, Yang, Shihai, Yang, Meihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524916/ https://www.ncbi.nlm.nih.gov/pubmed/28790918 http://dx.doi.org/10.3389/fphar.2017.00491 |
Ejemplares similares
-
First person – Xiao-Zhi Cheng
Publicado: (2019) -
Comparative In Vitro Dissolution of Two Commercially Available Er-Zhi-Wan Herbal Medicinal Products
por: Wang, M., et al.
Publicado: (2015) -
Multilevel data integration and molecular docking approach to systematically elucidate the underlying pharmacological mechanisms of Er-Zhi-Wan against hepatocellular carcinoma
por: Zheng, Shaoyan, et al.
Publicado: (2022) -
Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids
por: Yu, Yonghui, et al.
Publicado: (2020) -
System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of Zhi-zhu Wan for Functional Dyspepsia
por: Wang, Chun, et al.
Publicado: (2018)